US Stock MarketDetailed Quotes

ATXI Avenue Therapeutics

Watchlist
  • 2.1100
  • +0.1200+6.03%
Close Oct 18 16:00 ET
  • 2.1016
  • -0.0084-0.40%
Post 19:14 ET
3.02MMarket Cap0.06P/E (TTM)

Avenue Therapeutics Stock Analyst Ratings & Price Target

Analyst Rating

Updated: Aug 13, 2024

Based on 1 analysts giving stock ratings to Avenue Therapeutics in the past 3 months

Buy

  • Buy

    100.00%
  • Hold

    0.00%
  • Sell

    0.00%

Price Target

Updated: Aug 13, 2024

The average Avenue Therapeutics stock price target is 12.00 with a max estimate of 12.00 and a min estimate of 12.00

Detailed RatingsDetailed RatingsDetailed Ratings

Detailed Ratings

Receive timely notifications of rating changes

View more detailed ratings of institutions and analysts

View rating details page for historical data

Download APP

Analyst Ratings Disclaimer

Analysis

Analyst Rating

Updated: Aug 13, 2024

Buy

  • Buy

    100.00%
  • Hold

    0.00%
  • Sell

    0.00%

Price Target

Updated: Aug 13, 2024

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data